Market Cap

$152.4B

Volume

38.0M

Cash and Equivalents

$1.1B

EBITDA

$18.4B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$41.4B

Profit Margin

69.78%

52 Week High

$31.54

52 Week Low

$24.48

Dividend

6.40%

Price / Book Value

1.65

Price / Earnings

35.94

Price / Tangible Book Value

-4.20

Enterprise Value

$210.6B

Enterprise Value / EBITDA

10.58

Operating Income

$11.5B

Return on Equity

4.54%

Return on Assets

3.31

Cash and Short Term Investments

$10.0B

Debt

$67.9B

Equity

$92.6B

Revenue

$59.4B

Unlevered FCF

$13.3B

Sector

Pharmaceuticals

Category

N/A